Glypican 3 binds to GLUT1 and decreases glucose transport activity in hepatocellular carcinoma cells

GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis

(2009) Thomas Amann et al.   AMERICAN JOURNAL OF PATHOLOGY

RGS11 interacts preferentially with R7BP over Gαoa – Characterization of Gβ5-free RGS11

(2009) Yasar Saleem et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Proteomic Analysis of a PDEF Ets Transcription Factor-Interacting Protein Complex

(2009) Je-Yoel Cho et al.   JOURNAL OF PROTEOME RESEARCH

‘Two-Stage Double-Technique Hybrid (TSDTH)’ Identification Strategy for the Analysis of BMP2-Induced Transdifferentiation of Premyoblast C2C12 Cells to Osteoblast

(2009) Byung-Gyu Kim et al.   JOURNAL OF PROTEOME RESEARCH

Identification of Glypican3 as a novel GLUT4-binding protein

(2008) Akihiko Taguchi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells

(2008) Kiyotaka Nakano et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation

(2008) Ivan Stigliano et al.   BREAST CANCER RESEARCH AND TREATMENT

Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway

(2008) Wei Cheng et al.   CARCINOGENESIS

Glypican-3 Inhibits Hedgehog Signaling during Development by Competing with Patched for Hedgehog Binding

(2008) Mariana I. Capurro et al.   DEVELOPMENTAL CELL